Antipsychotic Agents: all 1,683 studies that test it
Page 11 of 17. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.
- An Study of Aripiprazole in the Treatment of Methamphetamine DependenceTerminatedNCT01813656Phase 4
- A Comparison of Risperidone and Aripiprazole for Treatment of Patirnts With Methamphetamine-Associated PsychosisTerminatedNCT01813643Phase 4
- Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of DeliriumCompletedNCT01811459Phase 3
- Asenapine for Bipolar DepressionTerminatedNCT01807741Phase 2
- Effectiveness and Safety of Amisulpride in Chinese Patients With SchizophreniaCompletedNCT01795183Phase 4
- Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose StrengthsCompletedNCT01788774Phase 1
- pRophylactic halopEriDol Use for Delirium in iCu patiEnts With a High Risk for DeliriumCompletedNCT01785290Phase 4
- Therapeutic Drug Monitoring and Pharmacokinetic Compartmental Analysis of Sulpiride After Oral Administration to Healthy VolunteersCompletedNCT01777685Not applicable
- Impulsivity and Thought Process Disorder in Patients With Active Suicidal Ideation and DepressionWithdrawnNCT01770600Not applicable
- Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective PsychosisStatus unknownNCT01765829Phase 3
- Haloperidol vs. Valproate in AgitationCompletedNCT01750541Phase 3
- A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum DisordersStatus unknownNCT01742390Phase 4
- Postoperative Vomiting in Children: Comparison Tri - Versus bi -ProphylaxisCompletedNCT01739985Not applicable
- Bioequivalence Study of Risperidone Tablet 1 mg Under Fasting ConditionCompletedNCT01722201Phase 1
- Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic SyndromeCompletedNCT01714011Phase 4
- Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders PatientsStatus unknownNCT01710163Phase 4
- A Study of the Combination of Multiple Doses of RO5285119 With a Single Dose of Risperidone in Healthy VolunteersCompletedNCT01708616Phase 1
- Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive DisorderCompletedNCT01696617Phase 4
- A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral AntipsychoticsCompletedNCT01685931Phase 4
- Evidence of Haloperidol Absorption After Topical AdministrationWithdrawnNCT01684969Early Phase 1
- A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental StutteringSuspendedNCT01684657Phase 3
- A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone PalmitateCompletedNCT01682161Phase 4
- Antagonism Research Between Antiemetics Agents and Acetaminophen in Thyroidectomy's Post-operative Analgesia.CompletedNCT01679093Phase 3
- Clinical Benefits of Seroquel XR in Anxiety DisorderStatus unknownNCT01672554Phase 3
- A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With SchizophreniaTerminatedNCT01670071Phase 4
- Clozapine Plasma Levels and the Relationship to the Genetic Polymorphism in Shizophrenic PatientsCompletedNCT01663077Phase 4
- Canadian Biomarker Integration Network for Depression StudyCompletedNCT01655706Phase 3
- Pharmacokinetic and Safety Evaluation of L-tetrahydropalmatine (l-THP) With Cocaine Exposure in People With a History of Cocaine UseCompletedNCT01631383Phase 1
- A Study to Evaluate the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents With Irritability Associated With Autistic DisorderCompletedNCT01624675Phase 3
- Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat SchizophreniaCompletedNCT01623713Phase 2
- Bioequivalence Study of Risperidone Tablet 1 mg Under Fed ConditionCompletedNCT01618760Phase 1
- Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689)CompletedNCT01617200Phase 3
- A Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of SchizophreniaTerminatedNCT01615185Phase 4
- Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to MonotherapyCompletedNCT01609153Phase 4
- A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five AntipsychoticsCompletedNCT01607762Phase 1
- Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed ConditionCompletedNCT01603186Phase 1
- Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fasting ConditionCompletedNCT01603173Phase 1
- A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic DrugTerminatedNCT01592201Phase 4
- Efficacy of Quetiapine XR Versus Divalproex on Clinical Outcome Quality of Sleep and Quality of Life in Bipolar DepressionWithdrawnNCT01587066Phase 4
- Autologous Angiogenic Cell Precursors (ACPs) for the Treatment of Peripheral Artery DiseaseCompletedNCT01584986Phase 2
- Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Open-label Pilot StudyWithdrawnNCT01584466Not applicable
- Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed ConditionsCompletedNCT01581879Phase 1
- Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting ConditionsCompletedNCT01581866Phase 1
- Crossover Bioequivalence Study of Quetiapine Fumarate 300 mg Tablets Under Steady State Fasted ConditionsCompletedNCT01570959Not applicable
- Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fasted ConditionsCompletedNCT01570907Not applicable
- Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fed ConditionsCompletedNCT01570894Not applicable
- Bioequivalence Study of Quetiapine Fumarate Tablets 300 mg Under Fasting ConditionCompletedNCT01566487Phase 1
- Change in Brain Metabolism and Cognitive Function by AripiprazoleCompletedNCT01562808Not applicable
- Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site CopenhagenCompletedNCT01555814Not applicable
- Effects of Quetiapine on Ultrastructural Hippocampal and Neurochemical Changes in Patients With Bipolar Disorder: Searching for Antidepressant and Mood Stabilising NeurophysiologyCompletedNCT01552837Not applicable
- Early Recognition and Optimal Treatment of Delirium in Patients With Advanced CancerCompletedNCT01539733Not applicable
- Haloperidol Prophylaxis in Older Emergency Department PatientsCompletedNCT01530308Phase 4
- Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy VolunteersCompletedNCT01529294Phase 1
- Quetiapine in the Treatment of Postpartum Depression (PPD) in Bipolar Disorder (BD), Type IICompletedNCT01527448Not applicable
- A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute SchizophreniaCompletedNCT01527305Phase 4
- Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot StudyTerminatedNCT01520350Phase 3
- Evaluation of the Effects of Treatment of Psycho-stimulant and Cannabis-dependent Users in IsraelStatus unknownNCT01510015Not applicable
- Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed ConditionCompletedNCT01503450Phase 1
- Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting ConditionCompletedNCT01503437Phase 1
- Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed StudyCompletedNCT01503424Phase 1
- Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01503398Phase 1
- Pre-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated PatientCompletedNCT01501123Not applicable
- Tolerability and Pharmacokinetics of Iloperidone in Adolescent PatientsCompletedNCT01495169Phase 1
- A Study of ALKS 9072 in Subjects With Chronic Stable SchizophreniaCompletedNCT01493726Phase 1
- Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive DisorderStatus unknownNCT01488266Not applicable
- Four Interventions in the Management of Psychomotor Agitation, Safety and Efficacy EvaluationCompletedNCT01485692Not applicable
- Quetiapine Compared With Placebo in the Management of FibromyalgiaCompletedNCT01458964Phase 4
- Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode SchizophreniaCompletedNCT01451736Phase 4
- POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic SchizophreniaCompletedNCT01450514Phase 2
- Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone PalmitateCompletedNCT01448720Phase 3
- Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia PatientsWithdrawnNCT01448499Not applicable
- Bergen Psychosis Project 2 - The Best Intro StudyCompletedNCT01446328Phase 4
- Comparison of Three Different Prophylactic Treatments of Postoperative Nausea and Vomiting (PONV) in ChildrenCompletedNCT01434017Phase 4
- Drug Interactions Between Paracetamol and Setrons in Pain ManagementCompletedNCT01432977Phase 3
- Aripiprazole for the Augmentation of Antidepressant TherapyCompletedNCT01429831Phase 4
- A PET Study in Healthy VolunteersCompletedNCT01424449Phase 1
- Major Depressive Disorder With Mixed FeaturesWithdrawnNCT01423240Phase 3
- Open-Label, Extension Study to 810P202CompletedNCT01416064Phase 2
- Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk PrediabeticsCompletedNCT01411930Phase 4
- Safety and Tolerability Comparison of Immediate and Controlled Release Formulations of EcopipamCompletedNCT01408394Phase 1
- Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind EyeCompletedNCT01404364Not applicable
- Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and FluvoxamineCompletedNCT01401491Phase 4
- Comparison of the Pharmacokinetics of Three Generic Medications and Their Respective Brand PreparationsStatus unknownNCT01400165Phase 1
- Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia PatientsCompletedNCT01399450Phase 4
- F-18 Altanserin PET Study of Patients Receiving ClozapineStatus unknownNCT01398189Not applicable
- Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)CompletedNCT01396291Phase 3
- Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)CompletedNCT01395992Phase 3
- A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective DisorderStatus unknownNCT01389908Not applicable
- Aripiprazole and Resistant Postpartum DepressionCompletedNCT01386086Phase 3
- Effects of Cariprazine on Cardiac Repolarization in Patients With SchizophreniaCompletedNCT01376076Phase 1
- A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT01364662Phase 2
- The Quietude Study: Quetiapine Use for Agitated DepressionTerminatedNCT01363310Phase 3
- The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude SlopeStatus unknownNCT01357967Phase 4
- Phase II Proof-of-concept Study of APD421CompletedNCT01303978Phase 2
- Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ DepressionCompletedNCT01303601Phase 4
- Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant DepressionCompletedNCT01282632Phase 1/2
- Paliperidone Palmitate Flexible Dosing in SchizophreniaCompletedNCT01281527Phase 3
- Typical Versus Atypical Antipsychotics; Occupation of Striatal Receptors and the Appearance of Extrapyramidal Symptomatology, in Healthy VolunteersStatus unknownNCT01259973Phase 1
- A Study of Paliperidone Palmitate in Japanese Patients With SchizophreniaCompletedNCT01258920Phase 3
- Effects of 'Seroquel-XR' on the Improvement of Neurocognitive Function in People At-risk Mental States(ARMS)Status unknownNCT01250847Phase 4